Microneedling for large pores: separate appearance from evidence

Microneedling is sometimes offered to make enlarged facial pores look less noticeable, but FDA’s listed legal marketing uses for microneedling medical devices do not give every device a general “pore reduction” indication. The directly relevant clinical evidence is limited: a small, nonrandomized comparison measured pore appearance after standard microneedling and another energy procedure, without establishing a reliable advantage between them. Ask which kind of pore visibility is being addressed, which exact device is used, and how improvement would be judged.¹²³

Pores are normal skin structures. “Shrink pores” can mean reducing the visible opening, clearing a plug, changing surrounding texture, or simply making the skin look smoother in certain lighting. Those are not interchangeable endpoints. A well-framed consultation starts with the specific appearance concern rather than a package name.

First identify why the pores look prominent

The American Academy of Dermatology describes several ways pores can look more noticeable: excess oil or blockage, skin irritation, sun-related changes, and loss of firmness. Its patient guidance focuses on making pores less visible, not removing them.²

This is an observation framework, not a way to diagnose skin at home. A clinician can decide whether acne, irritation, a scar, or another issue should be addressed first. The acne-scar microneedling guide addresses a different tissue target and evidence base.

What FDA authorization does and does not cover

FDA says it has legally authorized specific microneedling medical devices to improve the appearance of facial acne scars, facial wrinkles, and abdominal scars in patients age 22 or older. The exact decision record specifies the device, use and body area. FDA’s overview does not present a general medical-device authorization for enlarged pores.¹

That does not mean a clinician can never discuss an off-label cosmetic goal. It means a practice should not advertise “FDA cleared to shrink pores” solely because a pen is authorized for wrinkles or acne scars. Ask for the exact device model and regulatory record if a clearance claim is made. “FDA registered,” “professional grade,” and “cleared for facial wrinkles” each answer a different question.

Some superficial microneedling products that do not penetrate living skin and make only general appearance claims may not be medical devices at all, according to FDA. The procedure name alone therefore cannot tell you what FDA reviewed. Likewise, radiofrequency microneedling adds energy delivery and has its own risk and device context; data from an RF device cannot be silently transferred to a conventional needle pen.

What a pore study can support

A 2024 nonrandomized study enrolled 50 people seeking facial rejuvenation and improvement of “open pores.” Participants chose standard microneedling or fractional radiofrequency treatment, 25 per group. After three sessions, a dermatologist used a researcher-made rating scale to grade pore appearance. The study reported no statistically significant difference between the groups for its pore ratings at about three months.³

The design allows only a narrow interpretation. Self-selection can make the groups different before treatment. The outcome was an ordinal appearance rating, not a robust objective measure of pore anatomy or long-term maintenance. Its pore-outcome table accounts for only 19 of the 25 enrolled microneedling participants and 21 of the 25 radiofrequency participants, without explaining the missing ratings. There was no untreated comparison that would isolate a procedure effect from time, skin care, expectation, and assessment variation. The paper’s broad “superior” conclusion for microneedling goes further than its nonsignificant between-group pore comparison supports.

Evidence hygiene matters here. A separate 2024 acne-scar study sometimes cited for pore measurements was retracted in 2025. Its secondary pore numbers should not be treated as valid support for a microneedling package, regardless of how often they appear in search summaries.⁴

Small studies of RF microneedling, microneedling plus topical agents, or drug-assisted techniques may be hypothesis-generating, but those combinations answer different questions from plain microneedling. A before/after image or a study of a combined treatment cannot show how much of any observed change came from the needling alone.

Make the proposed endpoint observable

Ask the provider to name the goal before any procedure: fewer visible plugs, more even texture, or less noticeable pore openings in the same facial zone. If photos are used for follow-up, request similar lighting, distance, angle, skin care and timing. A filtered close-up and an unfiltered photo are not comparable evidence.

Also ask what treatment is proposed, who performs it, and how the practice handles contraindications, infection prevention, pigment concerns and follow-up. FDA’s consumer guidance describes possible short- and long-term effects and advises reviewing the specific device and provider. The RF microneedling safety guide addresses additional issues when energy is part of the procedure.¹

At a microneedling practice consultation, the best answer is modest and specific: identify the skin issue, show the exact device’s lawful claims, describe the limited pore-specific evidence, and agree on a way to assess appearance. That gives a reader a usable decision even if the marketing language says “poreless.”